Australia markets closed

Nanosphere Health Sciences Inc (2CG2.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.01500.0000 (0.00%)
At close: 08:04AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Cost of revenue
53.694
-
-
-
-
-
Gross profit
-328.037
-
-
-
-
-
Operating expenses
Research development
20.928
23.085
26.907
59.531
0
-
Selling general and administrative
175.973
196.993
235.877
296.543
532.555
-
Total operating expenses
215.07
236.793
283.876
386.001
565.625
-
Operating income or loss
-215.07
-236.793
-283.876
-386.001
-565.625
-
Interest expense
13.753
-
-
-0.013
-0.153
13.753
Total other income/expenses net
-0.79
8.666
2.124
29.718
-25.748
-
Income before tax
-215.86
-228.127
-281.752
-356.27
-591.22
-
Income from continuing operations
-215.86
-228.127
-281.752
-356.27
-591.22
-
Net income
-215.86
-228.127
-281.752
-356.27
-591.22
-
Net income available to common shareholders
-215.86
-228.127
-281.752
-356.27
-591.22
-
Basic EPS
-0.04
-0.02
-0.03
-0.05
-0.11
-
Diluted EPS
-0.04
-0.02
-0.03
-0.05
-0.11
-
Basic average shares
10,275
10,275
10,275
6,815
5,418
-
Diluted average shares
10,275
10,275
10,275
6,815
5,418
-